@WHO recommends against the use of ivermectin for #COVID19 except within clinical trials," Soumya Swaminathan, Chief Scientist at WHO tweeted. Ivermectin is used in the treatment of onchocerciasis (river blindness), strongyloidiasis and other diseases caused by soil-transmitted helminthiasis. The WHO earlier in March had said that the current evidence on the use of ivermectin to treat covid-19 patients is inconclusive. In a stark contrast of the voices against Ivermectin, a latest peer-reviewed research published last week has said that immediate global ivermectin use will end the covid-19 pandemic. To evaluate the efficacy of ivermectin in preventing covid-19, 3 RCT's and 5 observational controlled trial's including almost 2,500 patients all reported that ivermectin significantly reduces the risk of contracting covid-19 when used regularly, the scientists said.

Source: Mint May 11, 2021 13:40 UTC